265 related articles for article (PubMed ID: 24183791)
1. Early dietary treated patients with phenylketonuria can achieve normal growth and body composition.
Rocha JC; van Spronsen FJ; Almeida MF; Ramos E; Guimarães JT; Borges N
Mol Genet Metab; 2013; 110 Suppl():S40-3. PubMed ID: 24183791
[TBL] [Abstract][Full Text] [Related]
2. Dietary intake and nutritional status of patients with phenylketonuria in Taiwan.
Weng HL; Yang FJ; Chen PR; Hwu WL; Lee NC; Chien YH
Sci Rep; 2020 Sep; 10(1):14537. PubMed ID: 32883979
[TBL] [Abstract][Full Text] [Related]
3. The relationship between dietary intake, growth and body composition in Phenylketonuria.
Evans M; Truby H; Boneh A
Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria.
Dobbelaere D; Michaud L; Debrabander A; Vanderbecken S; Gottrand F; Turck D; Farriaux JP
J Inherit Metab Dis; 2003; 26(1):1-11. PubMed ID: 12872834
[TBL] [Abstract][Full Text] [Related]
5. Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy.
Acosta PB; Yannicelli S; Singh R; Mofidi S; Steiner R; DeVincentis E; Jurecki E; Bernstein L; Gleason S; Chetty M; Rouse B
J Am Diet Assoc; 2003 Sep; 103(9):1167-73. PubMed ID: 12963945
[TBL] [Abstract][Full Text] [Related]
6. Body protein in prepubertal children with phenylketonuria.
Allen JR; Baur LA; Waters DL; Humphries IR; Allen BJ; Roberts DC; Gaskin KJ
Eur J Clin Nutr; 1996 Mar; 50(3):178-86. PubMed ID: 8654332
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of physical development in children with classical phenylketonuria].
Bushueva TV; Borovik TE; Ladodo KS; Kuzenkova LM; Maslova OI; Gevorkyan AK
Vopr Pitan; 2015; 84(2):34-43. PubMed ID: 26841554
[TBL] [Abstract][Full Text] [Related]
8. Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature.
Huemer M; Huemer C; Möslinger D; Huter D; Stöckler-Ipsiroglu S
J Inherit Metab Dis; 2007 Oct; 30(5):694-9. PubMed ID: 17628756
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: impact on growth in PKU.
Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Andrade F; Llarena M; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; González D; Sánchez-Valverde F
Mol Genet Metab; 2013 Aug; 109(4):331-8. PubMed ID: 23810227
[TBL] [Abstract][Full Text] [Related]
10. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
[TBL] [Abstract][Full Text] [Related]
11. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
12. 6R-tetrahydrobiopterin treated PKU patients below 4 years of age: Physical outcomes, nutrition and genotype.
Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Llarena M; Andrade F; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; Peña-Quintana L; González D; Sánchez-Valverde F
Mol Genet Metab; 2015 May; 115(1):10-6. PubMed ID: 25882749
[TBL] [Abstract][Full Text] [Related]
13. Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients.
de Groot MJ; Hoeksma M; van Rijn M; Slart RH; van Spronsen FJ
Mol Genet Metab; 2012 Apr; 105(4):566-70. PubMed ID: 22300845
[TBL] [Abstract][Full Text] [Related]
14. Physical development in patients with phenylketonuria on dietary treatment: a retrospective study.
Belanger-Quintana A; Martínez-Pardo M
Mol Genet Metab; 2011 Dec; 104(4):480-4. PubMed ID: 21878401
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Phenylketonuria on Body Composition in Adults.
Barta AG; Becsei D; Kiss E; Sumánszki C; Simonová E; Reismann P
Ann Nutr Metab; 2022; 78(2):98-105. PubMed ID: 34872082
[TBL] [Abstract][Full Text] [Related]
17. Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients.
Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Andrade F; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Peña-Quintana L; Ruiz MA; González D; Sánchez-Valverde F
Clin Nutr; 2014 Aug; 33(4):702-17. PubMed ID: 24120886
[TBL] [Abstract][Full Text] [Related]
18. Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes.
Daly A; Högler W; Crabtree N; Shaw N; Evans S; Pinto A; Jackson R; Strauss BJ; Wilcox G; Rocha JC; Ashmore C; MacDonald A
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33923714
[TBL] [Abstract][Full Text] [Related]
19. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
de Sonneville LM; Huijbregts SC; van Spronsen FJ; Verkerk PH; Sergeant JA; Licht R
Mol Genet Metab; 2010; 99 Suppl 1():S10-7. PubMed ID: 20123462
[TBL] [Abstract][Full Text] [Related]
20. Protein insufficiency and linear growth restriction in phenylketonuria.
Arnold GL; Vladutiu CJ; Kirby RS; Blakely EM; Deluca JM
J Pediatr; 2002 Aug; 141(2):243-6. PubMed ID: 12183721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
